Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis.
BACKGROUND: Metformin is a first-line oral agent used in the treatment of type 2 diabetes, but glycaemic response to this drug is highly variable. Understanding the genetic contribution to metformin response might increase the possibility of personalising metformin treatment. We aimed to establish t...
Main Authors: | Zhou, K, Donnelly, L, Yang, J, Li, M, Deshmukh, H, Van Zuydam, N, Ahlqvist, E, Spencer, C, Groop, L, Morris, A, Colhoun, H, Sham, P, McCarthy, M, Palmer, C, Pearson, E |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2014
|
Registos relacionados
-
Heritability of variation in glycaemic response to metformin: A genome-wide complex trait analysis
Por: Zhou, K, et al.
Publicado em: (2014) -
Estimating heritability of glycaemic response to metformin using nationwide electronic health records and population-sized pedigree
Por: Iris N. Kalka, et al.
Publicado em: (2021-12-01) -
Variation in the glucose transporter gene SLC2A2 is associated with glycaemic response to metformin
Por: Kaixin, Z, et al.
Publicado em: (2016) -
Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with Type 2 diabetes: A Go-DARTS study
Por: Donnelly, L, et al.
Publicado em: (2011) -
Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study.
Por: Donnelly, L, et al.
Publicado em: (2011)